8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer)
Published . Updated .
Filed: 2026-10-07 AccNo: 0001193125-26-416251 Size: 149 KB Item 1.01: Entry into a Material Definitive Agreement
Directly affected
- RARE Ultragenyx Pharmaceutical
Named in this report.
Indirectly affected
- ACHC ACADIA HEALTHCARE COMPANY INC
GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ASND ASCENDIS PHARMA A/S
GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ATYR ATYR PHARMA INC COM NEW
GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- BBIO BRIDGEBIO PHARMA INC
GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- DVA DaVita HealthCare Partners, Inc.
GA selected DVA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- GEHC GE HEALTHCARE TECHNOLOGIES I
GA selected GEHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Filed: 2026-10-07 AccNo: 0001193125-26-416251 Size: 149 KB Item 1.01: Entry into a Material Definitive Agreement
Source: sec-edgar
Ultragenyx Pharmaceutical (RARE) since this story, compared with the market
Since the first closing price after “8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer),” Ultragenyx Pharmaceutical (RARE) is -1.34%. The S&P 500 fund (SPY) is -0.94% over the same days, a -0.40% difference versus the market.
Filings that name Ultragenyx Pharmaceutical (RARE) around 7 Oct 2026
- Gilbert Cisneros sell BridgeBio Pharma (BBIO) ($1,001 - $15,000). That is 8 days before publication, inside 30 days. The filing is listed beside the story “8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer).”
- Gilbert Cisneros buy Ultragenyx Pharmaceutical (RARE) ($1,001 - $15,000). That is 8 days before publication, inside 30 days. The filing is listed beside the story “8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer).”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 26 days before publication, inside 30 days. The filing is listed beside the story “8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer).”
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Ultragenyx Pharmaceutical (RARE)
Companies mentioned with this story
- RARE Ultragenyx Pharmaceutical
In “8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer),” Ultragenyx Pharmaceutical (RARE) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> RARE
- ACHC Acadia Healthcare
In “8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer),” Acadia Healthcare (ACHC) is linked, with no stored direction, medium confidence. Reason on file: GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ASND Ascendis Pharma A/S
In “8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer),” Ascendis Pharma A/S (ASND) is linked, with no stored direction, medium confidence. Reason on file: GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ATYR aTYR PHARMA
For “8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer),” aTYR PHARMA (ATYR) is linked, with no stored direction, medium confidence. Reason on file: GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- BBIO BridgeBio Pharma
For “8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer),” BridgeBio Pharma (BBIO) is linked, with no stored direction, medium confidence. Reason on file: GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- DVA Davita
For “8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer),” Davita (DVA) is linked, with no stored direction, medium confidence. Reason on file: GA selected DVA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- GEHC GE HealthCare Technologies
In “8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer),” GE HealthCare Technologies (GEHC) is linked, with no stored direction, medium confidence. Reason on file: GA selected GEHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
How “8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer)” reaches Ultragenyx Pharmaceutical (RARE)
“8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer)” (7 Oct 2026) reaches Ultragenyx Pharmaceutical (RARE) through this story.
What ties Ultragenyx Pharmaceutical (RARE) to the headline is this: SEC 8-K filing -> direct issuer disclosure -> RARE
Also listed, Acadia Healthcare (ACHC): GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Price levels for Ultragenyx Pharmaceutical (RARE)
ACHC traded between 26.75 and 32.03 across 20 sessions. The latest close on file is 30.20. ASND traded between 219.69 and 240.84 across 20 sessions. The latest close on file is 229.99. RARE traded between 12.88 and 15.73 across 11 sessions. The latest close on file is 15.07.
How strong the case is around Ultragenyx Pharmaceutical (RARE)
46 out of 100
“8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer)” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.